Global and China Uterine Fibroid Treatment Market Size, Status and Forecast 2020-2026

August 2020 | 95 pages | ID: GF689056B5BCEN
QYResearch

Abstracts

Global Uterine Fibroid Treatment Scope and Market Size
Uterine Fibroid Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Uterine Fibroid Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into

• Endometrial Ablation
• MRI Guided Procedures
• Hysterectomy
• Myomectomy
• Uterine Artery Embolization
• Radiofrequency Ablation
• Others

Market segment by Application, split into

• Hospital
• Clinic
• Other

Based on regional and country-level analysis, the Uterine Fibroid Treatment market has been segmented as follows:

• North America
• United States
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia-Pacific
• Latin America
• Mexico
• Brazil
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Uterine Fibroid Treatment market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study

• Blue Endo
• Boston Scientific Corporation
• CooperSurgical, Inc.
• KARL STORZ SE & Co. KG
• Myovant Sciences (Sumitovant Biopharma Ltd.)
• Halt Medical, Inc.
• LiNA Medical USA
• Merit Medical Systems
• Olympus Corporation
• Richard Wolf GmbH

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Uterine Fibroid Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.2.2 Endometrial Ablation
  1.2.3 MRI Guided Procedures
  1.2.4 Hysterectomy
  1.2.5 Myomectomy
  1.2.6 Uterine Artery Embolization
  1.2.7 Radiofrequency Ablation
  1.2.8 Others
1.3 Market by Application
  1.3.1 Global Uterine Fibroid Treatment Market Share by Application: 2020 VS 2026
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Uterine Fibroid Treatment Market Perspective (2015-2026)
2.2 Global Uterine Fibroid Treatment Growth Trends by Regions
  2.2.1 Uterine Fibroid Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Uterine Fibroid Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Uterine Fibroid Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Uterine Fibroid Treatment Players by Market Size
  3.1.1 Global Top Uterine Fibroid Treatment Players by Revenue (2015-2020)
  3.1.2 Global Uterine Fibroid Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Uterine Fibroid Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Uterine Fibroid Treatment Revenue
3.4 Global Uterine Fibroid Treatment Market Concentration Ratio
  3.4.1 Global Uterine Fibroid Treatment Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Uterine Fibroid Treatment Revenue in 2019
3.5 Key Players Uterine Fibroid Treatment Area Served
3.6 Key Players Uterine Fibroid Treatment Product Solution and Service
3.7 Date of Enter into Uterine Fibroid Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 UTERINE FIBROID TREATMENT BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Uterine Fibroid Treatment Historic Market Size by Type (2015-2020)
4.2 Global Uterine Fibroid Treatment Forecasted Market Size by Type (2021-2026)

5 UTERINE FIBROID TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Uterine Fibroid Treatment Historic Market Size by Application (2015-2020)
5.2 Global Uterine Fibroid Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Uterine Fibroid Treatment Market Size (2015-2026)
6.2 North America Uterine Fibroid Treatment Market Size by Type (2015-2020)
6.3 North America Uterine Fibroid Treatment Market Size by Application (2015-2020)
6.4 North America Uterine Fibroid Treatment Market Size by Country (2015-2020)
  6.4.1 United States
  6.4.2 Canada

7 EUROPE

7.1 Europe Uterine Fibroid Treatment Market Size (2015-2026)
7.2 Europe Uterine Fibroid Treatment Market Size by Type (2015-2020)
7.3 Europe Uterine Fibroid Treatment Market Size by Application (2015-2020)
7.4 Europe Uterine Fibroid Treatment Market Size by Country (2015-2020)
  7.4.1 Germany
  7.4.2 France
  7.4.3 U.K.
  7.4.4 Italy
  7.4.5 Russia
  7.4.6 Nordic
  7.4.7 Rest of Europe

8 CHINA

8.1 China Uterine Fibroid Treatment Market Size (2015-2026)
8.2 China Uterine Fibroid Treatment Market Size by Type (2015-2020)
8.3 China Uterine Fibroid Treatment Market Size by Application (2015-2020)
8.4 China Uterine Fibroid Treatment Market Size by Region (2015-2020)
  8.4.1 China
  8.4.2 Japan
  8.4.3 South Korea
  8.4.4 Southeast Asia
  8.4.5 India
  8.4.6 Australia
  8.4.7 Rest of Asia-Pacific

9 JAPAN

9.1 Japan Uterine Fibroid Treatment Market Size (2015-2026)
9.2 Japan Uterine Fibroid Treatment Market Size by Type (2015-2020)
9.3 Japan Uterine Fibroid Treatment Market Size by Application (2015-2020)
9.4 Japan Uterine Fibroid Treatment Market Size by Country (2015-2020)
  9.4.1 Mexico
  9.4.2 Brazil

10 SOUTHEAST ASIA

10.1 Southeast Asia Uterine Fibroid Treatment Market Size (2015-2026)
10.2 Southeast Asia Uterine Fibroid Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Uterine Fibroid Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Uterine Fibroid Treatment Market Size by Country (2015-2020)
  10.4.1 Turkey
  10.4.2 Saudi Arabia
  10.4.3 UAE
  10.4.4 Rest of Middle East & Africa

11KEY PLAYERS PROFILES

11.1 Blue Endo
  11.1.1 Blue Endo Company Details
  11.1.2 Blue Endo Business Overview
  11.1.3 Blue Endo Uterine Fibroid Treatment Introduction
  11.1.4 Blue Endo Revenue in Uterine Fibroid Treatment Business (2015-2020))
  11.1.5 Blue Endo Recent Development
11.2 Boston Scientific Corporation
  11.2.1 Boston Scientific Corporation Company Details
  11.2.2 Boston Scientific Corporation Business Overview
  11.2.3 Boston Scientific Corporation Uterine Fibroid Treatment Introduction
  11.2.4 Boston Scientific Corporation Revenue in Uterine Fibroid Treatment Business (2015-2020)
  11.2.5 Boston Scientific Corporation Recent Development
11.3 CooperSurgical, Inc.
  11.3.1 CooperSurgical, Inc. Company Details
  11.3.2 CooperSurgical, Inc. Business Overview
  11.3.3 CooperSurgical, Inc. Uterine Fibroid Treatment Introduction
  11.3.4 CooperSurgical, Inc. Revenue in Uterine Fibroid Treatment Business (2015-2020)
  11.3.5 CooperSurgical, Inc. Recent Development
11.4 KARL STORZ SE & Co. KG
  11.4.1 KARL STORZ SE & Co. KG Company Details
  11.4.2 KARL STORZ SE & Co. KG Business Overview
  11.4.3 KARL STORZ SE & Co. KG Uterine Fibroid Treatment Introduction
  11.4.4 KARL STORZ SE & Co. KG Revenue in Uterine Fibroid Treatment Business (2015-2020)
  11.4.5 KARL STORZ SE & Co. KG Recent Development
11.5 Myovant Sciences (Sumitovant Biopharma Ltd.)
  11.5.1 Myovant Sciences (Sumitovant Biopharma Ltd.) Company Details
  11.5.2 Myovant Sciences (Sumitovant Biopharma Ltd.) Business Overview
  11.5.3 Myovant Sciences (Sumitovant Biopharma Ltd.) Uterine Fibroid Treatment Introduction
  11.5.4 Myovant Sciences (Sumitovant Biopharma Ltd.) Revenue in Uterine Fibroid Treatment Business (2015-2020)
  11.5.5 Myovant Sciences (Sumitovant Biopharma Ltd.) Recent Development
11.6 Halt Medical, Inc.
  11.6.1 Halt Medical, Inc. Company Details
  11.6.2 Halt Medical, Inc. Business Overview
  11.6.3 Halt Medical, Inc. Uterine Fibroid Treatment Introduction
  11.6.4 Halt Medical, Inc. Revenue in Uterine Fibroid Treatment Business (2015-2020)
  11.6.5 Halt Medical, Inc. Recent Development
11.7 LiNA Medical USA
  11.7.1 LiNA Medical USA Company Details
  11.7.2 LiNA Medical USA Business Overview
  11.7.3 LiNA Medical USA Uterine Fibroid Treatment Introduction
  11.7.4 LiNA Medical USA Revenue in Uterine Fibroid Treatment Business (2015-2020)
  11.7.5 LiNA Medical USA Recent Development
11.8 Merit Medical Systems
  11.8.1 Merit Medical Systems Company Details
  11.8.2 Merit Medical Systems Business Overview
  11.8.3 Merit Medical Systems Uterine Fibroid Treatment Introduction
  11.8.4 Merit Medical Systems Revenue in Uterine Fibroid Treatment Business (2015-2020)
  11.8.5 Merit Medical Systems Recent Development
11.9 Olympus Corporation
  11.9.1 Olympus Corporation Company Details
  11.9.2 Olympus Corporation Business Overview
  11.9.3 Olympus Corporation Uterine Fibroid Treatment Introduction
  11.9.4 Olympus Corporation Revenue in Uterine Fibroid Treatment Business (2015-2020)
  11.9.5 Olympus Corporation Recent Development
11.10 Richard Wolf GmbH
  11.10.1 Richard Wolf GmbH Company Details
  11.10.2 Richard Wolf GmbH Business Overview
  11.10.3 Richard Wolf GmbH Uterine Fibroid Treatment Introduction
  11.10.4 Richard Wolf GmbH Revenue in Uterine Fibroid Treatment Business (2015-2020)
  11.10.5 Richard Wolf GmbH Recent Development

12ANALYST'S VIEWPOINTS/CONCLUSIONS

13APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Uterine Fibroid Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Endometrial Ablation
Table 4. Key Players of MRI Guided Procedures
Table 5. Key Players of Hysterectomy
Table 6. Key Players of Myomectomy
Table 7. Key Players of Uterine Artery Embolization
Table 8. Key Players of Radiofrequency Ablation
Table 9. Key Players of Others
Table 10. Global Uterine Fibroid Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Uterine Fibroid Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Uterine Fibroid Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Uterine Fibroid Treatment Market Share by Regions (2015-2020)
Table 14. Global Uterine Fibroid Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Uterine Fibroid Treatment Market Share by Regions (2021-2026)
Table 16. Uterine Fibroid Treatment Market Market Trends
Table 17. Uterine Fibroid Treatment Market Drivers
Table 18. Uterine Fibroid Treatment Market Challenges
Table 19. Uterine Fibroid Treatment Market Restraints
Table 20. Global Uterine Fibroid Treatment Revenue by Players (2015-2020) (US$ Million)
Table 21. Global Uterine Fibroid Treatment Market Share by Players (2015-2020)
Table 22. Global Top Uterine Fibroid Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Fibroid Treatment as of 2019)
Table 23. Global Uterine Fibroid Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Uterine Fibroid Treatment Product Solution and Service
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Uterine Fibroid Treatment Market Size by Type (2015-2020) (US$ Million)
Table 28. Global Uterine Fibroid Treatment Market Size Share by Type (2015-2020)
Table 29. Global Uterine Fibroid Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Uterine Fibroid Treatment Market Size Share by Application (2015-2020)
Table 31. Global Uterine Fibroid Treatment Market Size by Application (2015-2020) (US$ Million)
Table 32. Global Uterine Fibroid Treatment Market Size Share by Application (2021-2026)
Table 33. North America Uterine Fibroid Treatment Market Size by Type (2015-2020) (US$ Million)
Table 34. North America Uterine Fibroid Treatment Market Share by Type (2015-2020)
Table 35. North America Uterine Fibroid Treatment Market Size by Application (2015-2020) (US$ Million)
Table 36. North America Uterine Fibroid Treatment Market Share by Application (2015-2020)
Table 37. North America Uterine Fibroid Treatment Market Size by Country (US$ Million) (2015-2020)
Table 38. North America Uterine Fibroid Treatment Market Share by Country (2015-2020)
Table 39. Europe Uterine Fibroid Treatment Market Size by Type (2015-2020) (US$ Million)
Table 40. Europe Uterine Fibroid Treatment Market Share by Type (2015-2020)
Table 41. Europe Uterine Fibroid Treatment Market Size by Application (2015-2020) (US$ Million)
Table 42. Europe Uterine Fibroid Treatment Market Share by Application (2015-2020)
Table 43. Europe Uterine Fibroid Treatment Market Size by Country (US$ Million) (2015-2020)
Table 44. Europe Uterine Fibroid Treatment Market Share by Country (2015-2020)
Table 45. China Uterine Fibroid Treatment Market Size by Type (2015-2020) (US$ Million)
Table 46. China Uterine Fibroid Treatment Market Share by Type (2015-2020)
Table 47. China Uterine Fibroid Treatment Market Size by Application (2015-2020) (US$ Million)
Table 48. China Uterine Fibroid Treatment Market Share by Application (2015-2020)
Table 49. China Uterine Fibroid Treatment Market Size by Region (US$ Million) (2015-2020)
Table 50. China Uterine Fibroid Treatment Market Share by Region (2015-2020)
Table 51. Japan Uterine Fibroid Treatment Market Size by Type (2015-2020) (US$ Million)
Table 52. Japan Uterine Fibroid Treatment Market Share by Type (2015-2020)
Table 53. Japan Uterine Fibroid Treatment Market Size by Application (2015-2020) (US$ Million)
Table 54. Japan Uterine Fibroid Treatment Market Share by Application (2015-2020)
Table 55. Japan Uterine Fibroid Treatment Market Size by Country (US$ Million) (2015-2020)
Table 56. Japan Uterine Fibroid Treatment Market Share by Country (2015-2020)
Table 57. Southeast Asia Uterine Fibroid Treatment Market Size by Type (2015-2020) (US$ Million)
Table 58. Southeast Asia Uterine Fibroid Treatment Market Share by Type (2015-2020)
Table 59. Southeast Asia Uterine Fibroid Treatment Market Size by Application (2015-2020) (US$ Million)
Table 60. Southeast Asia Uterine Fibroid Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Uterine Fibroid Treatment Market Size by Country (US$ Million) (2015-2020)
Table 62. Southeast Asia Uterine Fibroid Treatment Market Share by Country (2015-2020)
Table 63. Blue Endo Company Details
Table 64. Blue Endo Business Overview
Table 65. Blue Endo Product
Table 66. Blue Endo Revenue in Uterine Fibroid Treatment Business (2015-2020) (US$ Million)
Table 67. Blue Endo Recent Development
Table 68. Boston Scientific Corporation Company Details
Table 69. Boston Scientific Corporation Business Overview
Table 70. Boston Scientific Corporation Product
Table 71. Boston Scientific Corporation Revenue in Uterine Fibroid Treatment Business (2015-2020) (US$ Million)
Table 72. Boston Scientific Corporation Recent Development
Table 73. CooperSurgical, Inc. Company Details
Table 74. CooperSurgical, Inc. Business Overview
Table 75. CooperSurgical, Inc. Product
Table 76. CooperSurgical, Inc. Revenue in Uterine Fibroid Treatment Business (2015-2020) (US$ Million)
Table 77. CooperSurgical, Inc. Recent Development
Table 78. KARL STORZ SE & Co. KG Company Details
Table 79. KARL STORZ SE & Co. KG Business Overview
Table 80. KARL STORZ SE & Co. KG Product
Table 81. KARL STORZ SE & Co. KG Revenue in Uterine Fibroid Treatment Business (2015-2020) (US$ Million)
Table 82. KARL STORZ SE & Co. KG Recent Development
Table 83. Myovant Sciences (Sumitovant Biopharma Ltd.) Company Details
Table 84. Myovant Sciences (Sumitovant Biopharma Ltd.) Business Overview
Table 85. Myovant Sciences (Sumitovant Biopharma Ltd.) Product
Table 86. Myovant Sciences (Sumitovant Biopharma Ltd.) Revenue in Uterine Fibroid Treatment Business (2015-2020) (US$ Million)
Table 87. Myovant Sciences (Sumitovant Biopharma Ltd.) Recent Development
Table 88. Halt Medical, Inc. Company Details
Table 89. Halt Medical, Inc. Business Overview
Table 90. Halt Medical, Inc. Product
Table 91. Halt Medical, Inc. Revenue in Uterine Fibroid Treatment Business (2015-2020) (US$ Million)
Table 92. Halt Medical, Inc. Recent Development
Table 93. LiNA Medical USA Company Details
Table 94. LiNA Medical USA Business Overview
Table 95. LiNA Medical USA Product
Table 96. LiNA Medical USA Revenue in Uterine Fibroid Treatment Business (2015-2020) (US$ Million)
Table 97. LiNA Medical USA Recent Development
Table 98. Merit Medical Systems Business Overview
Table 99. Merit Medical Systems Product
Table 100. Merit Medical Systems Company Details
Table 101. Merit Medical Systems Revenue in Uterine Fibroid Treatment Business (2015-2020) (US$ Million)
Table 102. Merit Medical Systems Recent Development
Table 103. Olympus Corporation Company Details
Table 104. Olympus Corporation Business Overview
Table 105. Olympus Corporation Product
Table 106. Olympus Corporation Revenue in Uterine Fibroid Treatment Business (2015-2020) (US$ Million)
Table 107. Olympus Corporation Recent Development
Table 108. Richard Wolf GmbH Company Details
Table 109. Richard Wolf GmbH Business Overview
Table 110. Richard Wolf GmbH Product
Table 111. Richard Wolf GmbH Revenue in Uterine Fibroid Treatment Business (2015-2020) (US$ Million)
Table 112. Richard Wolf GmbH Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Uterine Fibroid Treatment Market Share by Type: 2020 VS 2026
Figure 2. Endometrial Ablation Features
Figure 3. MRI Guided Procedures Features
Figure 4. Hysterectomy Features
Figure 5. Myomectomy Features
Figure 6. Uterine Artery Embolization Features
Figure 7. Radiofrequency Ablation Features
Figure 8. Others Features
Figure 9. Global Uterine Fibroid Treatment Market Share by Application: 2020 VS 2026
Figure 10. Hospital Case Studies
Figure 11. Clinic Case Studies
Figure 12. Other Case Studies
Figure 13. Uterine Fibroid Treatment Report Years Considered
Figure 14. Global Uterine Fibroid Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 15. Global Uterine Fibroid Treatment Market Share by Regions: 2020 VS 2026
Figure 16. Global Uterine Fibroid Treatment Market Share by Regions (2021-2026)
Figure 17. Global Uterine Fibroid Treatment Market Share by Players in 2019
Figure 18. Global Top Uterine Fibroid Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Fibroid Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Uterine Fibroid Treatment Revenue in 2019
Figure 20. North America Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. United States Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Canada Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Europe Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Germany Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. France Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. U.K. Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Italy Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Russia Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Nordic Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Rest of Europe Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Asia-Pacific Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. China Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Japan Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. South Korea Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Southeast Asia Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. India Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Australia Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Rest of Asia-Pacific Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Latin America Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Mexico Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Brazil Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Middle East & Africa Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Turkey Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Saudi Arabia Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. UAE Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Rest of Middle East & Africa Uterine Fibroid Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Blue Endo Revenue Growth Rate in Uterine Fibroid Treatment Business (2015-2020)
Figure 48. Boston Scientific Corporation Revenue Growth Rate in Uterine Fibroid Treatment Business (2015-2020)
Figure 49. CooperSurgical, Inc. Revenue Growth Rate in Uterine Fibroid Treatment Business (2015-2020)
Figure 50. KARL STORZ SE & Co. KG Revenue Growth Rate in Uterine Fibroid Treatment Business (2015-2020)
Figure 51. Myovant Sciences (Sumitovant Biopharma Ltd.) Revenue Growth Rate in Uterine Fibroid Treatment Business (2015-2020)
Figure 52. Halt Medical, Inc. Revenue Growth Rate in Uterine Fibroid Treatment Business (2015-2020)
Figure 53. LiNA Medical USA Revenue Growth Rate in Uterine Fibroid Treatment Business (2015-2020)
Figure 54. Merit Medical Systems Revenue Growth Rate in Uterine Fibroid Treatment Business (2015-2020)
Figure 55. Olympus Corporation Revenue Growth Rate in Uterine Fibroid Treatment Business (2015-2020)
Figure 56. Richard Wolf GmbH Revenue Growth Rate in Uterine Fibroid Treatment Business (2015-2020)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed